Adam Figliola
Family · Clermont, FLNPI 1225586696
Payments from drug & device makers
Across 192 payments — averaging $35.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$996
- Vanda Pharmaceuticals Inc.$843
- Paratek Pharmaceuticals, Inc.$579
- Axsome Therapeutics, Inc.$523
- Lilly USA, LLC$426
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$386
- plus $3K from 24 others
What the payments were for
- Food & beverage$6,721100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $996 |
| Vanda Pharmaceuticals Inc. | 22 | $843 |
| Paratek Pharmaceuticals, Inc. | 12 | $579 |
| Axsome Therapeutics, Inc. | 8 | $523 |
| Lilly USA, LLC | 9 | $426 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $386 |
| Otsuka America Pharmaceutical, Inc. | 3 | $364 |
| Tris Pharma Inc | 12 | $358 |
| Corium, LLC | 16 | $334 |
| Phadia US Inc. | 5 | $258 |
| Abbott | 4 | $254 |
| Supernus Pharmaceuticals, Inc. | 6 | $237 |
| GSK | 4 | $180 |
| Novo Nordisk | 3 | $168 |
| Pfizer | 8 | $154 |
| Amgen | 1 | $110 |
| Alkermes, Inc. | 1 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Sanofi Pasteur Inc. | 3 | $56 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $51 |
| Merck | 2 | $49 |
| Gilead | 3 | $44 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $38 |
| Ironshore Pharmaceuticals Inc. | 2 | $30 |
| UCB, Inc. | 1 | $29 |
| Cranial Technologies, Inc | 1 | $26 |
| Indivior Inc. | 1 | $23 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| Genentech USA, Inc. | 2 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUZYRA$480
- LYBALVI$407
- Fanapt$361
- Auvelity$351
- CAPLYTA$247
- REXULTI$243
- MOUNJARO$240
- VRAYLAR$210
- FREESTYLE LIBRE 3$182
- Ozempic$125
- BEXSERO$123
- ABILIFY ASIMTUFII$121
- ABILIFY MAINTENA$121
- Dyanavel XR$120
- QELBREE$118
- QULIPTA$111
- UBRELVY$111
- Repatha$110
How this compares
$6,721 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Other family in Clermont
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.